preview

GW Pharmaceuticals Executive Summary

Better Essays

Based in the United Kingdom, GW Pharmaceuticals was co-founded by Dr. Brian Whittle and Dr. Geoffrey Guy in 1988 (GW Pharmaceuticals, 2014) with the focuses of “discovering, developing and commercializing” medications which harness the therapeutic effects cannabis components for use in areas of oncology and Central Nervous System Disorders (GW Pharmaceuticals, 2014). GW’s lead product, Satives®, was the “world’s first plant derived cannabinoid prescription drug” with its main use being for the treatment of MS spasticity (GW Pharmaceuticals, 2014). The company is also developing Epidiolex® for the use of controlling pediatric epilepsy as well as researching many other avenues for product development (GW Pharmaceuticals, 2014). Since the initial public offering in 2013 on the NASDAQ Global Market, GW has rapidly grown and now the company “occupies a world leading position in cannabinoid science” (GW Pharmaceuticals, 2014). With patients as the driving force behind their efforts, …show more content…

GW Pharmaceuticals vision statement clearly outlines the positive way in which they intend to conduct themselves as a business where they are not only focused on profit but also the health and wellness of the consumer. Their main purpose is “to be the global leaders in prescription cannabinoid medicines, through the rapid cost-effective development of pharmaceutical products which address clear unmet needs” (GW Pharmaceuticals, 2014). Profit is key in any business as reflected by GW’s vision, but they also make it clear that they are invested in their consumers with their focus being to provide medications “which make a real difference to [the patients] quality of life” (GW Pharmaceuticals, 2014). Although GW does not have a distinct mission statement, they offer ways in

Get Access